91 results
Page 2 of 5
8-K
EX-1.1
eyva05bhlfp2jxiannr
4 Nov 21
Entry into a Material Definitive Agreement
4:58pm
424B5
rrsnh1 u8535yr
4 Nov 21
Prospectus supplement for primary offering
4:55pm
8-K
EX-1.1
cvrzh74gycrrqmxc84
2 Jul 20
Announces Pricing of $76.2 Million Public Offering
4:09pm
424B5
sqedccm4 fiuifek
2 Jul 20
Prospectus supplement for primary offering
4:06pm
424B5
mp82nj5z
1 Jul 20
Prospectus supplement for primary offering
4:12pm
8-K
EX-99
6ke wsk5aelo
6 May 20
Neoleukin Therapeutics Announces First Quarter 2020 Financial Results and Provides Business Update
4:01pm